Patent · US Expired

Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds

US5739141A · kind A · utility

4Cited by
9References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateApr 14, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to derivatives of 5-thia- and 5-selenopyrimidinone, which are useful as inhibitors of the enzymes glycinamide ribonucleotide formyl transferase (GARFT) and amino imidazole carboxamide ribonucleotide formyl transferase AICARFT), pharmaceutical compositions containing these derivatives, and methods of using these derivatives. The present invention is also directed to intermediates useful for preparing these derivatives and methods of preparing these intermediates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.